MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41416-024-02597-8

Медицинская библиотека · British journal of cancer · 2024

Tumorigenic role of tacrolimus through mTORC1/C2 activation in post-transplant renal cell carcinomas.

Moldvai Dorottya, Sztankovics Dániel, Dankó Titanilla, Vetlényi Enikő, Petővári Gábor, Márk Ágnes, Patonai Attila, Végső Gyula, Piros László, Hosszú Ádám, Pápay Judit, Krencz Ildikó, Sebestyén Anna

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Kidney transplant recipients (KTRs) face an increased risk of renal cell carcinoma (RCC), in which the immunosuppressive regimen plays an important role. This study aimed to identify intracellular signalling alterations associated with post-transplant (post-tx) tumour formation.

METHODS

Expression of mTOR-related proteins were analysed in kidneys obtained from end-stage renal disease (ESRD) patients and RCCs developed in KTRs or non-transplant patients. The effects of tacrolimus (TAC) and rapamycin (RAPA) on mTOR activity, proliferation, and tumour growth were investigated through different in vitro and in vivo experiments.

RESULTS

Elevated mTORC1/C2 activity was observed in post-tx RCCs and in kidneys of TAC-treated ESRD patients. In vitro experiments demonstrated that TAC increases mTOR activity in a normal tubular epithelial cell line and in the investigated RCC cell lines, moreover, promotes the proliferation of some RCC cell line. In vivo, TAC elevated mTORC1/C2 activity in ischaemic kidneys of mice and enhanced tumour growth in xenograft model.

CONCLUSIONS

We observed significantly increased mTOR activity in ischaemic kidneys and post-tx RCCs, which highlights involvement of mTOR pathway both in the healing or fibrotic processes of kidney and in tumorigenesis. TAC-treatment further augmented the already elevated mTOR activity of injured kidney, potentially contributing to tumorigenesis during immunosuppression.

Для цитирования: Moldvai Dorottya, Sztankovics Dániel, Dankó Titanilla, Vetlényi Enikő, Petővári Gábor, Márk Ágnes, Patonai Attila, Végső Gyula, Piros László, Hosszú Ádám, Pápay Judit, Krencz Ildikó, Sebestyén Anna. Tumorigenic role of tacrolimus through mTORC1/C2 activation in post-transplant renal cell carcinomas.. British journal of cancer. 2024. DOI: 10.1038/s41416-024-02597-8.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.